Department of Clinical Pharmacy

PRODUCED BY THE CALIFORNIA POISON CONTROL SYSTEM
FOR IMMEDIATE RELEASE

UCSF School of Pharmacy Dean Mary Anne Koda-Kimble, PharmD, will receive the 2010 Remington Honor Medal from the American Pharmacists Association (APhA) on March 13, 2010, at

Research: 30th anniversary as the nation's top National Institutes of Health-funded pharmacy school, Lightwood, Mandell, Kortemme, Coutsias, Keiser, Shoichet, Irwin, Laggner, Hert, Thomas, Edwards, Voigt, Levskaya, Lim, Weiner, Craik, Darragh, Schneider, Farady, Lou, Marks, Phojanakong, Hann....

UCSF School of Pharmacy faculty members Marilyn Stebbins, PharmD (image left), and Helene Levens Lipton, PhD (image right), received the 2010 Jane Boggess Advancement of Pharmacy Practice Award from the Pharmacy Foundation of California during the California Pharmacists Association February 4–7,...

Robert Day, PharmD, UCSF School of Pharmacy associate dean and emeritus faculty member, was inducted into the California Pharmacists Association Hall of Fame during the association's February 4-7, 2010 meeting in Long Beach, California.

Marilyn Stebbins, PharmD, is the first female recipient of the California Pharmacists Association Innovative Pharmacist of the Year award, which honors accomplishment, creativity, and value added to therapeutics or pharmacy practice.

The University of California, San Francisco-operated California Poison Control System (CPCS), which had already sent layoff notices to its employees January 15, 2010, has secured funding to rescind the notices and continue to care for Californians, through June 2010, via its free and immediate 24...

Helene Levens Lipton, PhD, faculty member in the UCSF School of Pharmacy, presents data in support of including pharmacists in the medical home model of health care. Her editorial appears in the November 23, 2009 issue of the Archives of Internal Medicine.

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of...

UCSF School of Pharmacy researcher Lisa Bero, PhD, served with UCSF School of Medicine colleagues Bernard Lo, MD, and Deborah Grady,